Will allogeneic CAR T cells for CD19+ malignancies take autologous CAR T cells 'off the shelf'?

被引：31
|
作者：
DiNofia, Amanda M. [1 ,2 ]
Grupp, Stephan A. [1 ,2 ]
机构：
[1] Childrens Hosp Philadelphia, Cellular Therapy & Transplant Sect, Canc Immunotherapy Program, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pediat, Div Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2021年 / 18卷 / 04期
关键词：
D O I：
10.1038/s41571-021-00485-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The question of whether allogeneic chimeric antigen receptor (CAR) T cells could replace autologous CAR T cell therapy has garnered considerable interest, but limited data have been available for comparisons to date. Now, Benjamin et al. have reported their experience with allogeneic anti-CD19 CAR T cells in 21 paediatric and adult patients with acute lymphoblastic leukaemia.
引用
收藏
页码：195 / 196
页数：2
相关论文
共 50 条
  • [1] Will allogeneic CAR T cells for CD19+ malignancies take autologous CAR T cells ‘off the shelf’?
    Amanda M. DiNofia
    Stephan A. Grupp
    Nature Reviews Clinical Oncology, 2021, 18 : 195 - 196
  • [2] "Off-the-Shelf" Allogeneic CAR T-Cells
    Landgren, C. Ola
    ONCOLOGY-NEW YORK, 2021, 35 (10): : 687 - 691
  • [3] GENERATION OF "OFF-THE SHELF" αCD19-CAR T CELLS FOR THE TREATMENT OF B CELL MALIGNANCIES
    Tristan-Manzano, M.
    Martin-Guerra, R.
    Maldonado, N.
    Sanchez-Hernandez, S.
    Cortijo, M.
    Maranon, C.
    Herrera, C.
    Carmona, M. D.
    Marchal, J. A.
    Benabdellah, K.
    Martin, F.
    HUMAN GENE THERAPY, 2018, 29 (11) : A3 - A3
  • [4] ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
    S. Depil
    P. Duchateau
    S. A. Grupp
    G. Mufti
    L. Poirot
    Nature Reviews Drug Discovery, 2020, 19 (3) : 185 - 199
  • [5] 'Off-the-shelf' allogeneic CAR T cells: development and challenges
    Depil, S.
    Duchateau, P.
    Grupp, S. A.
    Mufti, G.
    Poirot, L.
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (03) : 185 - 199
  • [6] Improvement of "off-the-shelf'' allogeneic CAR-T cells
    Pavlovic, K.
    Carmona, M. D.
    Maldonado, N.
    Tristan, M.
    Cortijo, M.
    Nogueras, S.
    Jimenez, R.
    Martin, F.
    Herrera, I. C.
    Benabdellah, K.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A87 - A87
  • [7] Allogeneic "Off-the-Shelf" CAR T cells: Challenges and advances
    Chen, Sophia
    van den Brink, Marcel R. M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2024, 37 (03)
  • [8] Minimally modified off-the-shelf allogeneic CAR T cells
    Loos, Pauline
    Evgin, Laura
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (03):
  • [9] A direct comparison of CAR NK cells and CAR T cells for CD19+malignancies
    Thakkar, Aarohi
    Lee, Dean
    Lamb, Margaret
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [10] Engineered hypoimmune allogeneic CAR T cells as potential off-the-shelf CAR T cell immunotherapies.
    Hu, Xiaomeng
    White, Kathy
    Gattis, Corie
    Clarke, Ryan
    Landry, Sam
    Basco, Ron
    Tham, Eleonore
    Luo, Emily
    Tucker, Andrew
    Bandoro, Christopher
    Chu, Elaine
    Young, Chi
    Manner, Karl
    Nho, Priscilla
    Lam, Ben
    Beauchesne, Pascal
    Foster, Aaron
    Dowdle, William E.
    Rebar, Edward J.
    Fry, Terry J.
    Schrepfer, Sonja
    CANCER RESEARCH, 2022, 82 (12)
12345